CMS releases information on Part B claims-based quality measure scoring for 2021

October 27, 2021
MIPS participants: A CMS system processing error caused rejections of certain quality data codes.
CMS releases information on Part B claims-based quality measure scoring for 2021

Excerpted from page 46 of the September/October 2021 edition of AOA Focus.
Written by the AOA’s Coding & Reimbursement Committee.

The Centers for Medicare & Medicaid Services (CMS) has announced that it has found issues with two quality measures that are sometimes reported by doctors of optometry. This is an issue on the CMS side and not due to physician error. The two measures impacted are:

  • Quality ID 001: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
  • Quality ID 117: Diabetes: Eye Exam

The issue identified only impacts those who are reporting these measures via Part B claims. There was a CMS system processing error that caused rejections of certain quality data codes for these two measures. The codes impacted are included below.

If you report one of the delineated codes, CMS will not score the corresponding measure for 2021. CMS will reduce the “total available measure achievement points” by 10 points for 2021 for those doctors who reported either of these measures and reported one of the noted quality data codes.

The quality data codes impacted are as follows:

Measure QID Measure Name Affected CPT II Quality Data Code
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) 3051F - Most recent hemoglobin A1c (HbA1c) level greater than or equal to 7% and less than 8%.
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) 3052F - Most recent hemoglobin A1c (HbA1c) level greater than or equal to 8% and less than or equal to 9%.
117 Diabetes Eye Exam 2023F - Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed; without evidence of retinopathy.
117 Diabetes Eye Exam 2025F - Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed; without evidence of retinopathy.
117 Diabetes Eye Exam 2033F - Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed; without evidence of retinopathy.


CMS has indicated if the code for the measure was not included in the list above (e.g., 2022F for the Diabetes: Eye Exam measure) you will still be scored for the measure. While CMS encourages reporting other quality measures for the year, doctors can still earn perfect scores by reporting other measures at high performance levels.

As a reminder, quality scores are assessed using the following formula:

Calculating Quality Performance Category Score

Ask the coding experts

If you have any questions regarding Medical Records and Coding, please submit them to Coding Experts Submission Form and one of our coding experts will be in contact with you.
Related News

CMS’ 2022 Medicare PFS decreases conversion factor, sets new policy goals

The final rule includes a list of updated payment policies, quality measures adjustments and telehealth changes for the 2022 calendar year. How AOA’s input shaped rulemaking and what it means for doctors.

New ICD-10 codes take effect Oct. 1: What they say about social determinants of health

In addition to the new codes for social determinants of patients' health, a new, billable diagnosis code was created to report encounters for immunizations.

If it sounds too good to be true, it probably is

In assessing new products, consider first what is best for your patients and practice—but also consider reimbursement related to new equipment.